NURS 5334 Obesity Case Study

Document Content and Description Below

Obesity Case Study Sally Chambless The University of Texas at Arlington College of Nursing and Health Innovation In partial fulfillment of the requirements of Advanced Pharmacology (NURS 5334) M... ary Davis, DNP, MSN, ANP-BC, ADM-BC July 28, 2018 OBESITY CASE STUDY 2 5334 CASE SUMMARY TABLE  Symptoms: List two pertinent signs and symptoms or risk factors  This patient has the following risk factors for obesity: years of inappropriate dieting with a history of being overweight since childhood, family history of obesity, history of gestational diabetes, and a lack of physical activity (Wells, Schwinghammer, DiPiro, and DiPiro, 2017, p. 609).  Symptoms of obesity present are patient’s BMI of 31.17 kg/m2 , hypertension, dyslipidemia, waist circumference of 100 cm, joint pain, and knee pain indicative of osteoarthritis (Wells et al., 2017, p. 609).  Recommended Drugs: List three recommended drugs as indicated for this diagnosis 1. Orlistat (Xenical) (Vallerand, Sanoski, & Deglin, 2013, p. 952) 2. Phentermine and Topiramate (Qsymia) (Lexicomp, 2017, p. 1786) 3. Naltrexone and Bupropion (Contrave) (Lexicomp, 2017, p. 1580)  Drug Categories and Subcategories: Identify the category of each recommended drug 1. Orlistat (Xenical) - Category: Weight control agent; Subcategory: Lipase inhibitor (Vallerand et al., 2013, p. 952) 2. Phentermine/topiramate (Qsymia) - Category: Anorexiant; Anticonvulsant; Subcategory: Sympathomimetic (Lexicomp, 2017, p. 1786) 3. Naltrexone and Bupropion (Contrave) - Category: Anorexiant; Antidepressant; [Show More]

Last updated: 1 year ago

Preview 1 out of 10 pages